- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Recurrent Head and Neck Squamous Cell Carcinoma in Japan
Total 611 results
-
ALX Oncology Inc.Eli Lilly and CompanyRecruitingGastric Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States, Spain, France, Korea, Republic of, Taiwan, United Kingdom, Japan, Singapore, Belgium, Czechia, Italy
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungJapan
-
Novartis PharmaceuticalsTerminatedMelanoma | Ovarian Neoplasms | Non-Small-Cell Lung Carcinoma | Other Solid TumorsSpain, Germany, Singapore, Switzerland, Japan, United States
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Recruiting
-
University of ToyamaUnknownSmall Cell Lung CancerJapan
-
Genomic Health®, Inc.TerminatedNon Small Cell Lung CarcinomaUnited States, Spain, Chile, France, Ireland, Japan, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-squamous Non-small-cell LungPoland, Korea, Republic of, Ukraine, United States, Argentina, Australia, Austria, Canada, France, Japan, New Zealand, Romania, Russian Federation, Taiwan, Turkey, United Kingdom, Brazil, Colombia, Germany, Spain
-
Novartis PharmaceuticalsTerminatedRenal Cell Carcinoma | Epithelial Ovarian CancerJapan, Australia, Belgium, Spain, United States, Switzerland
-
Novartis PharmaceuticalsRecruitingAdvanced EGFRmutant NonSmallSellLungCancer (NSCLC),KRAS G12-mutant NSCLC,Esophageal SquamousCellCancer (SCC),Head/Neck SCC,MelanomaSpain, Japan, Korea, Republic of, Taiwan, Netherlands, United States, Italy, Canada, Singapore
-
AbbVieRecruitingNon-Small Cell Lung CancerUnited States, Israel, Japan
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanCompletedNon-Small-Cell Lung CarcinomaJapan
-
AstraZenecaWithdrawnCancer | Non Small Cell Lung Cancer | Epithelial Ovarian CancerJapan
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
Novartis PharmaceuticalsCompletedNon-Small-Cell Lung CancerJapan
-
Hoffmann-La RocheRecruitingSmall Cell Lung Cancer | Neuroendocrine CarcinomaUnited States, Japan, Denmark, Spain, Poland
-
BayerCompletedThyroid NeoplasmsUnited States, Japan, Turkey, Russian Federation, India, Germany, France, Mexico, Philippines, Greece, Netherlands, Spain, Taiwan, Brazil, Egypt, Argentina, Algeria, Lebanon, Saudi Arabia
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of, Taiwan, Singapore, Japan
-
Novartis PharmaceuticalsRecruitingNon-small Cell Lung CancerUnited States, Korea, Republic of, Spain, Japan, Germany, Switzerland
-
AstraZenecaActive, not recruitingNon-Small-Cell Lung CarcinomaFrance, Spain, Thailand, Belgium, Korea, Republic of, Netherlands, United States, Brazil, Japan, China, Malaysia, Taiwan, Australia, Denmark
-
MedImmune LLCAstraZenecaCompletedCarcinoma, Non-Small-Cell LungUnited States, Korea, Republic of, Japan
-
Kyowa Kirin, Inc.RecruitingGastric Adenocarcinoma | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Esophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaJapan
-
Eli Lilly and CompanyCompletedMetastatic Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaGermany, Italy, Spain, United States, Hungary, Russian Federation, Poland, Belgium, Netherlands, France, Czechia, Mexico, Argentina, Canada, Denmark, Finland, Israel, Japan, Puerto Rico, United Kingdom
-
PfizerCompleted
-
Eli Lilly and CompanyCompletedCarcinoma, Non Small Cell LungTaiwan, Japan, Korea, Republic of, China
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCCompletedCarcinoma, Transitional Cell | Gastric Adenocarcinoma | Non-small Cell Lung Cancer | Biliary Tract Cancer | Adenocarcinoma of the Gastroesophageal JunctionGermany, United States, Spain, United Kingdom, France, Japan
-
Novartis PharmaceuticalsTerminatedMelanoma | Head and Neck Cancer | Pancreatic Cancer | Urothelial Cancer | NSCLC, Non Small Cell Lung Cancer | RCC, Renal Cell Cancer | DLBCL, Diffused Large B Cell Lymphoma | MSS, Microsatellite Stable Colon Cancer | TNBC, Triple Negative Breast Cancer | mCRPC, Metastatic Castration Resistant Prostate...Belgium, Italy, Taiwan, Germany, Spain, United States, Argentina, Australia, Austria, Czechia, France, Japan, Netherlands, Switzerland, Singapore
-
Taiho Oncology, Inc.Taiho Pharmaceutical Co., Ltd.TerminatedSmall Cell Lung Cancer (SCLC)Japan, Italy, Germany
-
Merck Sharp & Dohme LLCActive, not recruiting
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCCompletedStage IV Non-Small Cell Lung CancerSpain, United States, France, Japan
-
PfizerCompletedALK-positive Non-small-cell Lung CancerJapan
-
Novartis PharmaceuticalsCompletedStomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 ProteinTaiwan, Switzerland, Korea, Republic of, Germany, United States, Japan
-
Samsung Bioepis Co., Ltd.RecruitingNon-small Cell Lung Cancer Stage IVGeorgia, India, Romania, Spain, Germany, Japan
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingNon-Small Cell Lung Cancer | Colon Cancer | Medullary Thyroid Cancer | Any Solid TumorUnited States, Japan, Taiwan, Australia, Korea, Republic of, Israel, Spain, Switzerland, Singapore, France, Canada, Italy, Germany, United Kingdom, Hong Kong, Denmark
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedAdvanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell CarcinomaUnited States, France, Canada, Spain, Italy, Belgium, Austria, Denmark, Germany, Australia, Israel, Russian Federation, Czechia, Norway, Poland, Romania, Japan, Argentina, Ireland, Greece, United Kingdom, Brazil, Sweden, Finland
-
BeiGeneActive, not recruitingGastric, or Gastroesophageal Junction AdenocarcinomaUnited States, China, Spain, Korea, Republic of, Poland, Russian Federation, Taiwan, France, Turkey, Japan, Italy, United Kingdom, Puerto Rico
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
PfizerCompleted
-
Japan Multinational Trial OrganizationCompleted
-
Helsinn Healthcare SAICON Clinical ResearchRecruitingRET-altered Solid Tumors | RET-altered Non Small Cell Lung CancerUnited States, Japan
-
National Hospital Organization Kinki-chuo Chest...Unknown
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Australia, Japan
-
Daiichi SankyoRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Spain, Japan, Netherlands, Taiwan
-
AmgenZai Lab (China only)RecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaCanada, Japan, United States, Korea, Republic of, China, Italy, Australia, Sweden, Spain, Taiwan, France, Belgium, Denmark, Thailand, Turkey, Czechia, Bulgaria, Brazil, Norway, Mexico, Poland, Estonia, Israel, Greece, Romania, Chile, Peru, Po... and more
-
AmgenRecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States, Israel, Italy, Spain, Switzerland, Canada, Australia, Germany, United Kingdom, Austria, France, Japan, Taiwan, China, Belgium, Poland, Thailand, Czechia, Singapore, Hungary, Argentina, Brazil, Romania, Portuga... and more
-
BayerActive, not recruitingUrothelial CarcinomaUnited States, Korea, Republic of, Japan, Germany, Italy, Spain, Austria, France
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Australia, Japan, Korea, Republic of, Spain
-
BayerAmgenCompletedThyroid NeoplasmsFrance, China, Korea, Republic of, United States, Spain, Russian Federation, United Kingdom, Netherlands, Sweden, Austria, Italy, Bulgaria, Poland, Saudi Arabia, Germany, Japan, Belgium, Denmark
-
Chugai PharmaceuticalJapan Lung Cancer SocietyCompletedNon-small Cell Lung Cancer | Extensive Disease Small Cell Lung CancerJapan
-
PfizerCompletedRenal Cell CancerUnited States, United Kingdom, Japan